The sector is organized as a consortium of 18 partners with a matrix organization between the selected pathologies and the technological platforms.
A matrix organization
Technology platforms
- Medical Oncology
- in vitro cell lines and bioassays
- in vivo models
- in vivo pharmacology
- Anatomo-pathology
- Genomic analyses – sequencing , NGS…
- Human and mouse microbiome analyses – Metasequencing
- Biobanking
- Data base
- Data mining
Pathologies of interest
- Colorectal cancer
- Prostate cancer
- Lung cancer
- Breast cancer
- Ovary cancer
- Liver cancer
- Pancreas Cancer
- Lymphoma
- Myeloma
- Leukemia
6
SMEs
4
Pharmaceutical companies
8
Academic institutions
Overall budget
41
M€
Public financial support
13.4
M€
Duration of the project
7
years
Our Partners
Partnership
IMODI is an open consortium integrated medical and technological innovation, by synergizing the expertises of its members
- You have a know-how or an innovative technology that could benefits from the IMODI members expertise for its development/validation
- You have original tools or cancer models that could complement the actual IMODI platforms
- You have a research project that could be performed in collaboration with IMODI members
- You want to access the IMODI scientific or commercial network visibility
- You want to support the IMODI actions